[1]CHENG H,SUN X,JI X,et al.Risk factors and the potential of nomogram for predicting hospital-acquired pressure injuries［J］.Int Wound J,2020,17(4):974-986.
[2] JOHNSON DE,BURTNESS B,LEEMANS CR,et al.Head and neck squamous cell carcinoma［J］.Nat Rev Dis Primers,2020,6(1):92.
[3] LAGERGREN J,LAGERGREN P.Oesophageal cancer［J］.BMJ,2010,341:c6280.
[4] PAI SI,WESTRA WH.Molecular pathology of head and neck cancer:implications for diagnosis,prognosis,and treatment［J］.Annu Rev Pathol,2009,4:49-70.
[5] DA SILVA SD,HIER M,MLYNAREK A,et al.Recurrent oral cancer:current and emerging therapeutic approaches［J］.Front Pharmacol,2012,3:149.
[6] FITCHETT RC,ALDUS EJ,FITCHETT LR,et al.The lived experience of head and neck cancer patients receiving curative radiotherapy:A systematic review and meta-ethnography［J］.Psychooncology,2018,27(9):2077-2086.
[7] PENG F,LIAO M,QIN R,et al.Regulated cell death (RCD) in cancer:key pathways and targeted therapies［J］.Signal Transduct Target Ther,2022,7(1):286.
[8] LIU X,NIE L,ZHANG Y,et al.Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis［J］.Nat Cell Biol,2023,25(3):404-414.
[9] ZHENG P,ZHOU C,DING Y,et al.Disulfidptosis:a new target for metabolic cancer therapy［J］.J Exp Clin Cancer Res,2023,42(1):103.
[10]ZHENG T,LIU Q,XING F,et al.Disulfidptosis:a new form of programmed cell death［J］.J Exp Clin Cancer Res,2023,42(1):137.
[11]ZHAO S,WANG L,DING W,et al.Crosstalk of disulfidptosis-related subtypes,establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework［J］.Front Endocrinol (Lausanne),2023,14:1180404.
[12]QI C,MA J,SUN J,et al.The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma［J］.Aging (Albany NY),2023,15(11):5075-5095.
[13]LI XM,LIU SP,LI Y,et al.Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma［J］.Heliyon,2023,9(8):e18436.
[14]WANG Z,DU X,LIAN W,et al.A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning［J］.Front Genet,2023,14:1193944.
[15]HU G,YAO H,WEI Z,et al.A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma［J］.Sci Rep,2023,13(1):12403.
[16]NI L,YANG H,WU X,et al.The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma［J］.Aging (Albany NY),2023,15(15):7741-7759.
[17]XU K,ZHANG Y,YAN Z,et al.Identification of disulfidptosis related subtypes,characterization of tumor microenvironment infiltration,and development of DRG prognostic prediction model in RCC,in which MSH3 is a key gene during disulfidptosis［J］.Front Immunol,2023,14:1205250.
[18]ZHANG D,ZHANG X,LIU Z,et al.An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma［J］.Front Oncol,2023,13:1207068.
[19]XIN S,LI R,SU J,et al.A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma［J］.J Cancer Res Clin Oncol,2023,149(15):13925-13942.
[20]HUTTER C,ZENKLUSEN JC.The cancer genome atlas:Creating lasting value beyond its data［J］.Cell,2018,173(2):283-285.
[21]KOLETSI D,PANDIS N.Survival analysis,part 2:Kaplan-Meier method and the log-rank test［J］.Am J Orthod Dentofacial Orthop,2017,152(4):569-571.
[22]KOLETSI D,PANDIS N.Survival analysis,part 3:Cox regression［J］.Am J Orthod Dentofacial Orthop,2017,152(5):722-723.
[23]DEXTER F.Wilcoxon-Mann-Whitney test used for data that are not normally distributed［J］.AnesthAnalg,2013,117(3):537-538.
[24]SZKLARCZYK D,KIRSCH R,KOUTROULI M,et al.The STRING database in 2023:protein-protein association networks and functional enrichment analyses for any sequenced genome of interest［J］.Nucleic Acids Res,2023,51(D1):D638-D646.
[25]KANEHISA M,FURUMICHI M,TANABE M,et al.KEGG:new perspectives on genomes,pathways,diseases and drugs［J］.Nucleic Acids Res,2017,45(D1):D353-D361.
[26]OLIVEIRA ML,WAGNER VP,SANT'ANA FILHO M,et al.A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay［J］.Braz Oral Res,2015,29:S1806-83242015000100270.
[27]CHAMOLI A,GOSAVI AS,SHIRWADKAR UP,et al.Overview of oral cavity squamous cell carcinoma:Risk factors,mechanisms,and diagnostics［J］.Oral Oncol,2021,121:105451.
[28]SUN XY,XIAO M,FU M,et al.ALMS1-IT1:A key player in the novel disulfidptosis-related LncRNA prognostic signature for head and neck squamous cell carcinoma［J］.Biomolecules,2024,14(3):266.
[29]苟秋童，谢强，靳文珂，等.口腔鳞癌中预后相关miRNA的生物信息学分析及实验验证［J］.现代肿瘤医学，2023，31（16）：2988-2995.
GOU QT,XIE Q,JIN WK,et al.Bioinformatic analysis and experimental verification of prognostic miRNA in oral squamous cell carcinoma［J］.Modern Oncology，2023，31（16）：2988-2995.
[30]朱良啸，刘万超，王文惠，等.基于生物信息学筛选胰腺导管腺癌关键基因［J］.现代肿瘤医学，2020，28（22）：3862-3867.
ZHU LX，LIU WC，WANG WH,et al.Identification key genes of pancreatic ductal adenocarcinoma based on bioinformatics analysis［J］.Modern Oncology，2020，28（22）：3862-3867.
[31]满君，宋龙飞，白法瑞，等.小细胞肺癌差异表达基因的生物信息学分析［J］.现代肿瘤医学，2021，29（12）：2057-2062.
MAN J，SONG LF，BAI FR,et al.Bioinformatics analysis of differentially expressed genes in small cell lung cancer［J］.Modern Oncology，2021，29（12）：2057-2062.
[32]GINSBURG O,ASHTON-PROLLA P,CANTOR A,et al.The role of genomics in global cancer prevention［J］.Nat Rev Clin Oncol,2021,18(2):116-128.
[33]GANINI C,AMELIO I,BERTOLO R,et al.Global mapping of cancers:The Cancer Genome Atlas and beyond［J］.Mol Oncol,2021,15(11):2823-2840.
[34]SPERL LE,RUHRNOSSL F,SCHILLER A,et al.High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane［J］.EMBO J,2021,40(20):e107159.
[35]WANG YD,CAI N,WU XL,et al.OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway［J］.Cell Death Dis,2013,4(8):e760.
[36]LIU C,ZHANG A,CHENG L,et al.miR-410 regulates apoptosis by targeting Bak1 in human colorectal cancer cells［J］.Mol Med Rep,2016,14(1):467-473.